Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

The Brigham and Women's Hospital identifies SMOC2 inhibitors

Sep. 26, 2017

FDA accepts for review sNDA for mirabegron in combination with solifenacin for overactive bladder

Sep. 14, 2017

Bayer enters kidney disease collaboration with Vanderbilt University Medical Center

Sep. 12, 2017

MK-3866 studied in patients with impaired renal function

Sep. 12, 2017

Avadel enters license agreement for U.S. and Canadian rights to Noctiva

Sep. 6, 2017

Enrollment completed in phase IIb study of BGS-649 for hypogonadotropic hypogonadism

Sep. 5, 2017

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Sep. 1, 2017

Apricus resubmits Vitaros NDA

Aug. 30, 2017

Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy

Aug. 30, 2017

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...